About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 1140   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Intravitreal diclofenac versus intravitreal bevacizumab in persistent diabetic macular edema: Anatomical and functional outcome
Amal ElBendary,Amr H. Elkannishy
Saudi Journal of Ophthalmology.2018;32(4)303
2Opening eyes to nanomedicine: Where we are, challenges and expectations on nanotherapy for diabetic retinopathy
Elisa J. Campos,António Campos,Joăo Martins,António Francisco Ambrósio
Nanomedicine: Nanotechnology, Biology and Medicine.2017;13(6)2101
3Incidence of endophthalmitis after intravitreal injections at a tertiary care hospital
Sidra Zafar,Arsalan Hamid,Syed Usman Bin Mahmood,Maqsood Ahmad Burq,Natasha Maqsood
Canadian Journal of Ophthalmology.2018;53(2)94
4Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and Pyroptosis
Rubens P. Homme,Mahavir Singh,Avisek Majumder,Akash K. George,Kavya Nair,Harpal S. Sandhu,Neetu Tyagi,David Lominadze,Suresh C Tyagi
Frontiers in Physiology.2018;9(2)94
5mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
Steven Hyun Seung Lee,Joo Yong Lee,Jun-Sub Choi,Hee Jong Kim,Jin Kim,Seho Cha,Kyoung Jin Lee,Ha-Na Woo,Keerang Park,Heuiran Lee,Zhijian Wu
PLOS ONE.2022;17(6)e0269951
Kocatepe Tip Dergisi.2017;18(1)37
7Curcumolide reduces diabetic retinal vascular leukostasis and leakage partly via inhibition of the p38MAPK/NF-? B signaling
Yuan Cai,Wencan Li,Hongfeng Tu,Nanmei Chen,Zhipeng Zhong,Pengcheng Yan,Jianyong Dong
Bioorganic & Medicinal Chemistry Letters.2017;27(8)1835
8Multiple roles of apelin/APJ system in eye diseases
Jingshun Luo,Qun Zhao,Zhiyue Li,Linxi Chen
9Intravitreally Administered Soluble VEGF Receptor-1 Variant Tested as a Potential Gene Therapeutic for Diabetic Retinopathy
Steven Hyun Seung Lee,Joo Yong Lee,Im Kyeung Kang,Jun-Sub Choi,Hee Jong Kim,Jin Kim,Seho Cha,Kyoung Jin Lee,Ha-Na Woo,Keerang Park,Heuiran Lee,Dao Pan
Advances in Cell and Gene Therapy.2022;2022(8)1
10Compound Danshen Dripping Pill for Treating Early Diabetic Retinopathy: A Randomized, Double-Dummy, Double-Blind Study
Dan Luo,Yali Qin,Wei Yuan,Hui Deng,Youhua Zhang,Ming Jin
Evidence-Based Complementary and Alternative Medicine.2015;2015(8)1
11Drug, delivery and devices for diabetic retinopathy (3Ds in DR)
Jayabalan Nirmal,Krishna Radhakrishnan,Miguel Moreno,Jayaganesh V. Natarajan,Augustinus Laude,Tock Han Lim,Subbu Venkatraman,Rupesh Agrawal
Expert Opinion on Drug Delivery.2016;13(11)1625
12Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNFa induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation
Sivasankar Shanmuganathan,Narayanasamy Angayarkanni
Vascular Pharmacology.2018;108(11)23
13Apelin-13 Is an Early Promoter of Cytoskeleton and Tight Junction in Diabetic Macular Edema via PI-3K/Akt and MAPK/Erk Signaling Pathways
Yang Li,Yu-jing Bai,Yan-rong Jiang,Wen-zhen Yu,Xuan Shi,Li Chen,Jing Feng,Gui-bo Sun
BioMed Research International.2018;2018(11)1
14Stationary Treatment Compared with Individualized Chinese Medicine for Type 2 Diabetes Patients with Microvascular Complications: Study Protocol for a Randomized Controlled Trial
Jian Huo,Li-sha Liu,Wen-yuan Jian,Jie-ping Zeng,Jun-guo Duan,Xue-jing Lu,Shuo Yin
Chinese Journal of Integrative Medicine.2018;24(10)728

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal